References
- Ronsmans C, Graham WJ. Maternal mortality: Who, when, where, and why. Lancet 2006;368:1189–200.
- World Health Organization. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2003, 5th edn. Geneva: WHO; 2007.
- Potts M. Abortion perspectives. Eur J Contracept Reprod Health Care 2010;15:157–9.
- Amy JJ. The shortest lecture on fertility control. Eur J Contracept Reprod Health Care 2009;14:321–3.
- Center for Reproductive Rights. The world's abortion laws. New York; 2008. Retrieved 12 January 2011 from: http://reproductiverights.org/sites/crr.civicactions.net/files/pub_fac_abortionlaws2008.pdf
- Barbosa RM, Arilha M. The Brazilian experience with Cytotec. Stud Fam Plann 1993;24:236–40.
- Viggiano M, Faúndes A, Borges AL, et al. Disponibilidade de misoprostol e complicações de aborto provocado em Goiânia. J Bras Ginecol 1996;106:55–61.
- Faúndes A, Santos LC, Carvalho M, Gras C. Post-abortion complications after interruption of pregnancy with misoprostol. Adv Contracept 1996;12:1–9.
- Miller S, Lechman T, Campbell M, et al. Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: A temporal association. BJGO 2005;112:1291–6.
- Briozzo L, ed. Iniciativas Sanitarias contra el Aborto Provocado en Condiciones de Riesgo. Montevideo: ARENA; 2007.
- Briozzo L, Vidiella G, Vidarte B, et al. Induced abortion under unsafe conditions. Health emergencies and maternal mortality in Uruguay. The current situation and medical initiatives for safe motherhood. Rev Med Uruguay 2002;18:4–14.
- Comisión Nacional para el Monitoreo y Reducción de las Muertes de Mujeres por Causa del Embarazo, Parto, Cesárea, Puerperio y Aborto. Ministerio de Salud Pública. Informe 2007–2009. Retrieved 10 January 2011 from: www.msp.gub.uy/andocasociado.aspx? 3920,18451